BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2987288)

  • 1. Increased cyclic nucleotide phosphodiesterase (PDE) and calmodulin activities in soluble fraction of Graves' thyroid: analysis of increase in Ca+2 dependence of PDE activities.
    Yagura T; Nagata I; Kuma K; Uchino H
    J Clin Endocrinol Metab; 1985 Jun; 60(6):1180-6. PubMed ID: 2987288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytosolic and membrane-bound cyclic nucleotide phosphodiesterases from guinea pig cardiac ventricles.
    Muller B; Stoclet JC; Lugnier C
    Eur J Pharmacol; 1992 Mar; 225(3):263-72. PubMed ID: 1325367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification and characterization of bovine lung calmodulin-dependent cyclic nucleotide phosphodiesterase. An enzyme containing calmodulin as a subunit.
    Sharma RK; Wang JH
    J Biol Chem; 1986 Oct; 261(30):14160-6. PubMed ID: 3021730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calmodulin-like activity and calcium-dependent phosphodiesterase in purified cells of the rat zona glomerulosa and zona fasciculata.
    Koletsky RJ; Brown EM; Williams GH
    Endocrinology; 1983 Aug; 113(2):485-90. PubMed ID: 6307640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization and selective inhibition of cyclic nucleotide phosphodiesterase isozymes in canine tracheal smooth muscle.
    Torphy TJ; Cieslinski LB
    Mol Pharmacol; 1990 Feb; 37(2):206-14. PubMed ID: 2154670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation of an enzymatically active cross-linked complex between brain cyclic nucleotide phosphodiesterase and 3-(2-pyridyldithio)propionyl-substituted calmodulin.
    Kincaid RL
    Biochemistry; 1984 Mar; 23(6):1143-7. PubMed ID: 6324862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in cyclic nucleotide phosphodiesterase activity and calmodulin concentration in heart muscle of cardiomyopathic hamsters.
    Masunaga R; Nagasaka A; Sawai Y; Hayakawa N; Nakai A; Hotta K; Kato Y; Hishida H; Takahashi H; Naka M; Shimada Y; Tanaka T; Hidaka H; Itoh M
    J Mol Cell Cardiol; 2004 Sep; 37(3):767-74. PubMed ID: 15350849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular cloning of a cDNA encoding the "61-kDa" calmodulin-stimulated cyclic nucleotide phosphodiesterase. Tissue-specific expression of structurally related isoforms.
    Sonnenburg WK; Seger D; Beavo JA
    J Biol Chem; 1993 Jan; 268(1):645-52. PubMed ID: 7678006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of two forms of cyclic nucelotide phosphodiesterase from rabbit heart.
    Tkachuk VA; Lazarevich VG; Severin SE
    Adv Myocardiol; 1982; 3():541-52. PubMed ID: 6302789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclic 3',5'-nucleotide phosphodiesterase activities in the thyroid glands of patients with various disorders.
    Nagasaka A; Hidaka H
    J Clin Endocrinol Metab; 1980 Apr; 50(4):726-33. PubMed ID: 6245100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphodiesterase and its Ca2+-dependent activating factor in bovine thyroid.
    Yagura T; Azuma Y; Akazawa Y; Nagata I; Uchino H
    Endocrinology; 1978 Nov; 103(5):1534-40. PubMed ID: 218780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of the dihydropyridine calcium antagonist, CD-349, with calmodulin.
    Tanaka M; Muramatsu M; Aihara H; Otomo S
    Biochem Pharmacol; 1990 Sep; 40(5):991-6. PubMed ID: 2167684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial biochemical and functional characterization of cyclic nucleotide phosphodiesterase isozymes in canine colonic smooth muscle.
    Barnette MS; Manning CD; Price WJ; Barone FC
    J Pharmacol Exp Ther; 1993 Feb; 264(2):801-12. PubMed ID: 7679736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of selective inhibitors on cyclic nucleotide phosphodiesterases of rabbit aorta.
    Ahn HS; Crim W; Romano M; Sybertz E; Pitts B
    Biochem Pharmacol; 1989 Oct; 38(19):3331-9. PubMed ID: 2554921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ca2+-calmodulin-activated cyclic nucleotide phosphodiesterase from the rabbit myometrium].
    Osipenko AA; Prishchepa LA; Kurskiĭ MD
    Ukr Biokhim Zh (1978); 1986; 58(4):26-31. PubMed ID: 3016961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benzylisoquinoline compounds inhibit the ability of calmodulin to activate cyclic nucleotide phosphodiesterase.
    Hu ZY; Chen SL; Hao ZG; Huang WL; Peng SX
    Cell Signal; 1989; 1(2):181-5. PubMed ID: 2561985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calmodulin antagonistic action of KS-504a, a novel metabolite of the fungus Mollisia ventosa.
    Nakanishi S; Kuroda K; Osawa K; Kase H
    Agric Biol Chem; 1990 Oct; 54(10):2697-702. PubMed ID: 1369297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of troponin I on the Ca-binding properties of calmodulin and activation of cyclic nucleotide phosphodiesterase by Ca ions].
    Men'shikov MIu; Rybin VO; Tkachuk VA
    Dokl Akad Nauk SSSR; 1981; 258(5):1250-4. PubMed ID: 6266797
    [No Abstract]   [Full Text] [Related]  

  • 19. [Separation and investigation of the regulatory properties of two forms of cyclic nucleotide phosphodiesterase from rabbit heart--sensitive and insensitive to Ca-dependent regulator protein].
    Tkachuk VA; Lazarevich VG; Men'shikov MIu; Severin SE
    Biokhimiia; 1978 Sep; 43(9):1622-30. PubMed ID: 214170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular distribution and pharmacological sensitivity of low Km cyclic nucleotide phosphodiesterase isozymes in human cardiac muscle from normal and cardiomyopathic subjects.
    Silver PJ; Allen P; Etzler JH; Hamel LT; Bentley RG; Pagani ED
    Second Messengers Phosphoproteins; 1990; 13(1):13-25. PubMed ID: 2286932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.